Cargando…

Randomized transcoronary delivery of CD34(+) cells with perfusion versus stop-flow method in patients with recent myocardial infarction: Early cardiac retention of (99m)Tc-labeled cells activity

BACKGROUND: For transcoronary progenitor cells’ administration, injections under flow arrest (over-the-wire balloon technique, OTW) are used universally despite lack of evidence for being required for cell delivery or being effective in stimulating myocardial engraftment. Flow-mediated endothelial r...

Descripción completa

Detalles Bibliográficos
Autores principales: Musialek, Piotr, Tekieli, Lukasz, Kostkiewicz, Magdalena, Majka, Marcin, Szot, Wojciech, Walter, Zbigniew, Zebzda, Anna, Pieniazek, Piotr, Kadzielski, Andrzej, Banys, R. Pawel, Olszowska, Maria, Pasowicz, Mieczyslaw, Zmudka, Krzysztof, Tracz, Wieslawa
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3032199/
https://www.ncbi.nlm.nih.gov/pubmed/21161463
http://dx.doi.org/10.1007/s12350-010-9326-z
Descripción
Sumario:BACKGROUND: For transcoronary progenitor cells’ administration, injections under flow arrest (over-the-wire balloon technique, OTW) are used universally despite lack of evidence for being required for cell delivery or being effective in stimulating myocardial engraftment. Flow-mediated endothelial rolling is mandatory for subsequent cell adhesion and extravasation. METHODS: To optimize cell directing toward the coronary endothelium under maintained flow, the authors developed a cell-delivery side-holed perfusion catheter (PC). Thirty-four patients (36-69 years, 30 men) with primary stent-assisted angioplasty-treated anterior MI (peak TnI 151 [53-356]ng/dL, mean[range]) were randomly assigned to OTW or PC autologous (99)Tc-extametazime-labeled bone marrow CD34(+) cells (4.34 [0.92-7.54] × 10(6)) administration at 6-14 days after pPCI (LVEF 37.1 [24-44]%). Myocardial perfusion ((99m)Tc-MIBI) and labeled cells’ activity were evaluated (SPECT) at, respectively, 36-48 h prior to and 60 min after delivery. RESULTS: In contrast to OTW coronary occlusions, no intolerance or ventricular arrhythmia occurred with PC cells’ administration (P < .001). One hour after delivery, 4.86 [1.7-7.6]% and 5.05 [2.2-9.9]% activity was detected in the myocardium (OTW and PC, respectively, P = .84). Labeled cell activity was clearly limited to the (viable) peri-infarct zone in 88% patients, indicating that the infarct core zone may be largely inaccessible to transcoronary-administered cells. CONCLUSIONS: Irrespective of the transcoronary delivery method, only ≈5% of native (i.e., non-engineered) CD34(+) cells spontaneously home to the injured myocardium, and cell retention occurs preferentially in the viable peri-infarct zone. Although the efficacy of cell delivery is not increased with the perfusion method, by avoiding provoking ischemic episodes PC offers a rational alternative to the OTW delivery.